The new imaging modality of positron emission tomography (PET)/magnetic resonance imaging (MRI) was introduced in the U.S. market last summer. The Siemens Biograph mMR (molecular MR) gained U.S. Food and Drug Administration (FDA) 510(k) clearance as the first dedicated PET/MRI system. It is the only system to combine both modalities into one machine, allowing simultaneous imaging of location, function and metabolic activity of organs in a single image.
If you enjoy this content, please share it with a colleague
- Read more about PET/MRI Enters the U.S. Market
- Log in or register to post comments